Evidence map›Paper›PMID 42534224›Full record

ArticleMedicine international

Crohn's disease and ulcerative colitis in β-thalassemia major: A report of two cases and a brief review of the literature.

Trwska A Amin, Luqman K H Rasool, Choman H Abdulqadir, Shaho F Ahmed, Rawa M Ali, Karokh H Salih, Dana T Gharib, Hoshmand R Asaad, Hiwa O Abdullah, Fahmi H Kakamad and 1 more

Abstract readCase Reports
In one paragraph

Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Trwska A AminDepartment of Hematology, Thalassaemia and Congenital Blood Diseases Center, Sulaymaniyah 46001, Iraq.
Luqman K H RasoolDepartment of Hematology, Thalassaemia and Congenital Blood Diseases Center, Sulaymaniyah 46001, Iraq.
Choman H AbdulqadirDepartment of Hematology, Thalassaemia and Congenital Blood Diseases Center, Sulaymaniyah 46001, Iraq.
Shaho F AhmedDepartment of Endocrinology, Smart Health Tower, Sulaymaniyah 46001, Iraq.
Rawa M AliDepartment of Pathology, Smart Health Tower, Sulaymaniyah 46001, Iraq.
Karokh H SalihDepartment of Basic Medical Sciences, College of Medicine, University of Sulaimani, Sulaymaniyah 46001, Iraq.
Dana T GharibDepartment of Gastroenterology and Hepatology, Smart Health Tower, Sulaymaniyah 46001, Iraq.
Hoshmand R AsaadDepartment of Gastroenterology and Hepatology, Smart Health Tower, Sulaymaniyah 46001, Iraq.
Hiwa O AbdullahDepartment of Scientific Affairs, Smart Health Tower, Sulaymaniyah 46001, Iraq.
Fahmi H KakamadDepartment of Scientific Affairs, Smart Health Tower, Sulaymaniyah 46001, Iraq.
Zana B NajmaddenResearch Center, University of Halabja, Halabja 46018, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The co-occurrence of β-thalassemia major and inflammatory bowel disease is exceedingly rare, yet clinically important, as overlapping manifestations such as severe anemia, fatigue, abdominal pain and dysentery may mask the underlying inflammatory bowel disease and delay diagnosis. The patients described in the present case report exhibited markedly elevated levels of inflammatory markers and fecal calprotectin levels (>1,000 µg/g); these findings, together with colonoscopic and histopathological findings, enabled the diagnosis of both major inflammatory bowel disease subtypes, namely Crohn's disease and ulcerative colitis. These cases add to the limited literature available by demonstrating that inflammatory bowel disease should be considered in patients with β-thalassemia major presenting with persistent gastrointestinal symptoms, particularly when symptoms are disproportionate to baseline disease manifestations. Early clinical suspicion, prompt diagnostic evaluation, and multidisciplinary management are crucial for preventing further clinical deterioration, minimizing complications and improving long-term outcomes. However, further studies are warranted to clarify the potential pathophysiological association and establish optimal management strategies for this rare coexistence.

Indexed as

adolescentCrohn's diseaseinflammatory bowel diseaseulcerative colitisβ-thalassemia major

Identifiers

PMID42534224
PMCPMC13419975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.